| | | Sponsored by: Catalent Join our experts as they share insights on: R&D Leadership During the Pandemic: John Chiminski, Chair & CEO Technology Integrators in Cell & Gene Therapy: Julien Meissonnier, VP & CSO A Novel Approach for High-Expressing CHO Cell Line Engineering: Greg Bleck, Ph.D., Global Head of R&D, Biologics |
|
|---|
|
| | | Sponsored by: CMIC Largest CRO in Japan with 1,200+ CRAs Involved in more than 80% of new drug development in Japan Connected with 2,600+ clinical sites in Asia-Pacific Among top 3 largest CDMOs in Japan Schedule a Virtual Meeting with Us at BIO! |
|
|---|
|
| | | Sponsored by: BioVectra With COVID-19, the pressure to reduce development times is high. Learn how we are leveraging our process science expertise and engineering experience to enable rapid scale-up while reducing manufacturing CoGs. Read about our approach here and meet with our team at BIO Digital: [email protected] |
|
|---|
|
| | | Sponsored by: AbbVie As a continuous manufacturing process, extrusion was cemented in pharmaceutical manufacturing in 1980s with market launch of sustained-release Verapamil, which contains embedded crystalline active pharmaceutical ingredient (API) in polymers. Following the Verapamil launch, researchers have turned to hot melt extrusion (HME) as an effective enabling technology to manufacture amorphous solid dispersions (ASDs) for poorly soluble compounds.
Click here to learn more. |
|
|---|
|
| | | Presented by: Acorn AI by Medidata, a Dassault Systèmes company
June 9, 2020 | 11am ET / 8am PT Join industry experts as they propose best practices for incorporating translational omic data in clinical development in order to yield novel insights and improve patient / study outcomes. Register now. |
|
|---|
|
| | | Presented by: Thermo Fisher Scientific
June 12, 2020 | 1pm ET / 10am PT Join usfor a live webcast that will announce our progress on the 2020 investments to our Pharma Services business and provide focused insight on Thermo Fisher Scientific's expanding gene therapy capabilities. We will also cover an update on our strategy to ensure the delivery of drugs to customers and patients in lieu of the COVID-19 outbreak, as well as our evolving direct response to the virus through several ongoing projects. Register Now. |
|
|---|
|
|
